Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Clinical trial NCT03714373 · COMPLETED
Trial details
- NCT number
- NCT03714373
- Sponsor
- Soleno Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2023-08-17
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.